Diagnostic Test & Biomarker Research for Parkinson's Disease

Research into diagnostic test & biomarker research approaches for Parkinson's Disease. AI-powered analysis of mechanisms, evidence, and clinical status.

About Diagnostic Test & Biomarker Research

Research into diagnostic tests, biomarkers, imaging modalities, liquid biopsies, and laboratory panels for disease evaluation, staging, and treatment monitoring. Focused on identifying the most informative tests for each clinical scenario.

About Parkinson's Disease

2026 Parkinson's treatment advances: alpha-synuclein targeting, LRRK2 gene therapy, nicotinamide riboside trials. AI-analyzed with safety scores.

Standard of Care: Levodopa/Carbidopa, dopamine agonists, MAO-B inhibitors, deep brain stimulation — primarily dopamine replacement and symptom control.